NEW YORK (GenomeWeb) – Pacific Biosciences reported after the close of the market Wednesday that its first quarter 2014 revenues more than doubled year over year and grew 27 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q1 revenues of $11.6 million, compared to $5.6 million in Q1 2013 and up from $9.1 million in Q4 2013. It beat the consensus Wall Street estimate of $10.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.